Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Namodenoson

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Can-Fite Explores Namodenoson Veterinary Partnerships at BioFIT
    Can-Fite Explores Namodenoson Veterinary Partnerships at BioFIT

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193378/0/en/Can-Fite-to-Advance-New-Veterinary-Partnership-Opportunities-for-Namodenoson-at-the-BioFIT-2025-Conference.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Can-Fite's Namodenoson Yields 9-Yr Cure in Advanced Liver Cancer
    Can-Fite's Namodenoson Yields 9-Yr Cure in Advanced Liver Cancer

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3189858/0/en/Can-Fite-9-Year-Survival-with-Complete-Cure-in-an-Advanced-Liver-Cancer-Patient-Treated-with-Namodenoson.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Can-Fite’s Namodenoson Treats Esophageal Varices in Cirrhosis
    Can-Fite’s Namodenoson Treats Esophageal Varices in Cirrhosis

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3149846/0/en/Can-Fite-Reports-Complete-Resolution-of-Esophageal-Varices-in-Decompensated-Cirrhosis-Patient-Treated-with-Namodenoson.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share
    Can-Fite's Namodenoson Hits 50% Enrollment in Phase 2a Study
    Can-Fite's Namodenoson Hits 50% Enrollment in Phase 2a Study

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3123927/0/en/Pancreatic-Cancer-Phase-2a-Study-with-Can-Fite-s-Namodenoson-Achieved-Over-50-Enrollment-Milestone.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    U.S. Medical Centers Seek Authorization for Namodenoson
    U.S. Medical Centers Seek Authorization for Namodenoson

    17 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/17/3063424/0/en/Following-FDA-Compassionate-Use-Approval-for-Pancreatic-Carcinoma-with-Can-Fite-s-Namodenoson-Leading-U-S-Medical-Centers-Seek-Authorization-for-their-Patients.html

    GLOBENEWSWIRE
    17 Apr 2025
    Share Share
    Can-Fite: FDA Approves Use of Namodenoson in Pancreatic Cancer
    Can-Fite: FDA Approves Use of Namodenoson in Pancreatic Cancer

    18 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/18/3044514/0/en/Can-Fite-FDA-Approved-Compassionate-Use-Treatment-with-Namodenoson-in-a-Pancreatic-Cancer-Patient.html

    GLOBENEWSWIRE
    18 Mar 2025
    Share Share